MedPath

Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage

Not Applicable
Conditions
Cicatrix, Hypertrophic
Keloid
Interventions
Drug: Silicone gel (Dermatix®)
Registration Number
NCT00565552
Lead Sponsor
University Hospital Schleswig-Holstein
Brief Summary

So far the evaluation of scar treatment was based on subjective criteria. The patient groups were divided into treated versus non-treated.

In this study we use patients undergoing ear reconstruction with autologous rib cartilage. The thoracic scar of harvesting the rib cartilage is routinely reopened after 3 month during second stage of reconstruction. Therefore we have a ideal model of clinical, physiological and histological scar evaluation in a homologous patient group.

All patients randomly treat one half of the scar with a silicone gel (Dermatix). The other half is untreated as an internal control.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • patients with high grade microtia requiring a reconstruction with autologous rib cartilage
Exclusion Criteria
  • diabetes mellitus
  • vascular disease
  • known allergic reaction to silicone

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Silicone gel (Dermatix®)Each patient uses the silicone gel on one half of the scar, leaving the other one blank as an internal control.
Primary Outcome Measures
NameTimeMethod
Beausang's scar scale, skin elasticity (Cutometer®), skin moisture (Corneometer®), skin color (Chromameter®, Mexameter®), histological evaluation (HE, elastica, actin etc.)45 minutes
Secondary Outcome Measures
NameTimeMethod
allergic reaction complianceretrospective

Trial Locations

Locations (1)

University Hospital Schleswig-Holstein

🇩🇪

Luebeck, Germany

© Copyright 2025. All Rights Reserved by MedPath